4//SEC Filing
Gagnon Suzanne 4
Accession 0001437749-19-010779
CIK 0001029125other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 7:28 PM ET
Size
7.0 KB
Accession
0001437749-19-010779
Insider Transaction Report
Form 4
Gagnon Suzanne
DirectorChief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-05-21+84,100→ 84,100 totalExercise: $2.95Exp: 2029-05-21→ Common Stock (84,100 underlying) - Award
Employee Stock Option (right to buy)
2019-05-21+40,300→ 40,300 totalExercise: $2.95From: 2019-05-21Exp: 2029-05-21→ Common Stock (40,300 underlying)
Footnotes (1)
- [F1]Immediately exercisable as to 25% of the shares and scheduled to vest with respect to 25% of the shares on each of May 21, 2020, May 21, 2021 and May 21, 2022.
Documents
Issuer
Sun BioPharma, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001652855
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 7:28 PM ET
- Size
- 7.0 KB